Stock Market & Financial Investment News

News Breaks July 13, 2012 09:20 EDT TRIB Trinity Biotech Plc target raised to $14.50 from $13 at Roth Capital Roth Capital increased its target on Trinity after the company reported higher than expected EPS. The firm maintains a Buy rating. News For TRIB From The Last 14 Days Check below for free stories on TRIB the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for TRIB Sign up for a free trial to see the rest of the stories you've been missing.